Zacks Research Has Positive Estimate for COO Q3 Earnings

The Cooper Companies, Inc. (NASDAQ:COO) – Equities research analysts at Zacks Research raised their Q3 2027 earnings estimates for shares of Cooper Companies in a research report issued on Thursday, March 26th. Zacks Research analyst Team now forecasts that the medical device company will earn $1.25 per share for the quarter, up from their prior forecast of $1.24. The consensus estimate for Cooper Companies’ current full-year earnings is $3.98 per share.

COO has been the subject of a number of other reports. Weiss Ratings upgraded Cooper Companies from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, January 12th. Wall Street Zen upgraded Cooper Companies from a “hold” rating to a “buy” rating in a research report on Saturday, February 28th. Needham & Company LLC boosted their price target on Cooper Companies from $99.00 to $101.00 and gave the company a “buy” rating in a research note on Friday, March 6th. Barclays upped their price objective on shares of Cooper Companies from $98.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, March 6th. Finally, Wells Fargo & Company increased their price objective on shares of Cooper Companies from $72.00 to $82.00 and gave the stock an “equal weight” rating in a research note on Friday, December 5th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Cooper Companies has a consensus rating of “Moderate Buy” and an average target price of $90.79.

Cooper Companies Trading Down 0.7%

Shares of NASDAQ:COO opened at $69.31 on Monday. The business’s 50 day simple moving average is $78.56 and its 200 day simple moving average is $76.23. Cooper Companies has a 1 year low of $61.78 and a 1 year high of $89.83. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.34 and a quick ratio of 0.79. The company has a market capitalization of $13.52 billion, a P/E ratio of 34.31, a P/E/G ratio of 1.80 and a beta of 1.02.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, March 5th. The medical device company reported $1.10 EPS for the quarter, topping the consensus estimate of $1.03 by $0.07. The company had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.02 billion. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. The business’s revenue for the quarter was up 6.2% on a year-over-year basis. During the same period last year, the firm earned $0.92 earnings per share. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS.

Hedge Funds Weigh In On Cooper Companies

Institutional investors have recently modified their holdings of the business. Capital World Investors boosted its stake in Cooper Companies by 25.7% in the third quarter. Capital World Investors now owns 10,551,592 shares of the medical device company’s stock valued at $723,417,000 after buying an additional 2,159,233 shares in the last quarter. State Street Corp raised its stake in Cooper Companies by 2.4% during the fourth quarter. State Street Corp now owns 8,793,747 shares of the medical device company’s stock worth $720,736,000 after acquiring an additional 207,195 shares in the last quarter. Wellington Management Group LLP raised its stake in Cooper Companies by 332.9% during the third quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock worth $424,043,000 after acquiring an additional 4,756,178 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in shares of Cooper Companies by 58.8% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock worth $494,123,000 after acquiring an additional 2,231,568 shares during the last quarter. Finally, Sustainable Growth Advisers LP boosted its stake in shares of Cooper Companies by 22.1% in the 3rd quarter. Sustainable Growth Advisers LP now owns 4,132,535 shares of the medical device company’s stock valued at $283,327,000 after purchasing an additional 747,476 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.